Literature DB >> 17709688

Comparison of protocols for surveillance of methicillin-resistant Staphylococcus aureus (MRSA): medical staff vs ICU patients.

Seungok Lee1, Yeon-Joon Park, Eun-Jee Oh, Jimin Kahng, Jin Hong Yoo, In-Hee Jeong, Young-Mi Kwon, Kyungja Han.   

Abstract

To compare the sensitivity of various protocols for methicillin-resistant Staphylococcus aureus (MRSA) surveillance, active surveillance for detecting MRSA nasal colonization was performed on 97 members of the medical staff and 218 patients in the Intensive Care Unit (ICU) of a university hospital. Duplicate nasal swabs were collected from each participant. One was plated directly on a blood agar plate (D-BAP) and observed at 24 and 48 hr. Another was incubated overnight in tryptic soy broth (TSB) with 6.5% NaCl, and subcultured on both BAP (B-BAP) and mannitol salt agar with 4 mg/L of oxacillin (B-MSAOXA). The MRSA colonization rate was similar in the medical staff and patient samples (16.5% vs 11.9%, p = 0.285). Among the medical staff members, the sensitivity of MRSA detection was the same (93.8%) in D-BAP and B-BAP. In the ICU patients, which are a high-risk group, the sensitivity of MRSA detection was improved by adding a pre-enrichment step (73.1% on D-BAP vs 96.2% on B-BAP). The simple direct plating protocol was sufficiently sensitive for the medical staff members, but pre-enrichment was an essential step to increase detection of MRSA in the ICU patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17709688

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  Multicenter Evaluation of the Xpert MRSA NxG Assay for Detection of Methicillin-Resistant Staphylococcus aureus in Nasal Swabs.

Authors:  Melanie L Yarbrough; David K Warren; Karen Allen; Dennis Burkholder; Robert Daum; Curtis Donskey; Dennis Knaack; Anthony LaMarca; Larissa May; Loren G Miller; David M Parenti; Lance Peterson; Thean Yen Tan; Raymond Widen; Diana R Hernandez; Donna M Wolk; C A Burnham
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.